WhiteLab Genomics

AI genomics company that combines biological data-guided rational design and AI to predict optimal molecular constructs for genomic medicine, optimizing drug design for safety and efficacy across diverse modalities such as AAV, lentivirus, and lipid nanoparticles.

VisitClaim or join

Founded: Not disclosed
Headquarters: Paris, Île-de-France, France; Boston, MA, USA
Company size: Not disclosed
Products tracked: 3

Products by WhiteLab Genomics

3 products

ALFRED AIProprietary AI platform that accelerates target discovery and drug design for genomic medicine, combining advanced algorithms, curated databases, and computational biology to op...0.00 reviewsDrug Discovery & Biotech

Cell Surface Protein IdentificationAdvanced deep learning method that predicts whether a protein is located at the cell surface based solely on its amino acid sequence, leveraging the curated UniProt dataset and...0.00 reviewsDrug Discovery & Biotech

AAV Capsid EngineeringComputational approach leveraging Protein Language Models and Reinforcement Learning to engineer AAV capsids, generating novel amino acid sequences in variable region VIII aimed...0.00 reviewsDrug Discovery & Biotech

Pricing for WhiteLab Genomics

Contact sales

Contact WhiteLab Genomics for current plans, volume pricing, and enterprise terms.

Trust profile

Security and compliance

No compliance claims have been published for this company.